Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / Common stock, par value $0.0001 per share
Symbol
VVOS on Nasdaq
Shares outstanding
6,713,803
Price per share
$1.62
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
658,093
Total reported value
$1,335,932
% of total 13F portfolios
0%
Share change
-28,634
Value change
-$421,186
Number of holders
18
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
V-CO Investors LLC 20% +100% $4,188,594 +$2,583,360 1,342,498 +161% SP Manager LLC 09 Jun 2025
LUO DAWEI 8.5% $3,432,096 572,016 Dawei Luo 08 Jul 2025
INTRACOASTAL CAPITAL, LLC 5% $796,804 297,315 Mitchell P. Kopin 22 Dec 2024

As of 31 Dec 2025, 18 institutional investors reported holding 658,093 shares of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS). This represents 9.8% of the company’s total 6,713,803 outstanding shares.

Institutional Holders of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 658,093 $1,335,932 -$421,186 $2.03 18
2025 Q3 686,727 $2,129,135 +$875,070 $3.10 22
2025 Q2 402,082 $1,271,158 +$424,559 $3.16 18
2025 Q1 281,633 $802,423 -$1,021,557 $2.85 19
2024 Q4 466,818 $2,003,111 +$1,082,494 $4.29 19
2024 Q3 245,048 $630,697 +$156,010 $2.61 22
2024 Q2 186,896 $433,846 -$444,091 $2.22 18
2024 Q1 133,960 $646,578 -$323,172 $4.83 13
2023 Q4 250,612 $3,117,234 +$3,117,234 $12.44 14